I C U Medical Inc (ICUI) 125.47 $ICUI Shares of ICUI Up

New Post Public Reply Private Reply Replies (0) Message Board

Sep 2, 2016 at 11:01 AM

I C U Medical Inc (ICUI) 125.47 $ICUI

Shares of ICUI Up 25.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Sep 01, 1:33PM CDT
SmarTrend identified an Uptrend for ICU Medical (NASDAQ:ICUI) on March 21st, 2016 at $99.62. In approximately 5 months, ICU Medical has returned 25.13% as of today's recent price of $124.65.
ICUI: 125.47 (+0.26)

ICU Medical Reaches Analyst Target Price
ETFChannel.com - Wed Aug 10, 6:38AM CDT
In recent trading, shares of ICU Medical, Inc. have crossed above the average analyst 12-month target price of $124.00, changing hands for $126.32/share.
ICUI: 125.47 (+0.26)

SmarTrend Watching for Potential Pullback in Shares of ICU Medical After 7.15% Gain
Comtex SmarTrend(R) - Tue Aug 09, 4:26PM CDT
ICU Medical (NASDAQ:ICUI) traded in a range yesterday that spanned from a low of $119.28 to a high of $128.93. Yesterday, the shares gained 7.1%, which took the trading range above the 3-day high of $118.31 on volume of 166,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ICUI: 125.47 (+0.26)

Here's 5 Medical Stocks Soaring After Earnings Today
Ryan McQueeney - Zacks Investment Research - Tue Aug 09, 1:36PM CDT
Check out these five medical-related companies that are in the green following their most recent reports.
ENDP: 20.54 (+0.31), ICUI: 125.47 (+0.26), VRX: 29.19 (+0.07), OPK: 9.28 (-0.01), NVRO: 96.56 (+0.54)

ICU Medical, Inc. Announces Second Quarter 2016 Results
GlobeNewswire - Mon Aug 08, 3:05PM CDT
ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy, oncology and critical care applications, today announced financial results for the second quarter ended June 30, 2016.
ICUI: 125.47 (+0.26)

Medical Product Stocks' Earnings on Aug 8: NVRO, ICUI & More
Zacks Equity Research - Zacks Investment Research - Fri Aug 05, 6:40AM CDT
The Q2 results so far portrayed a better picture compared to the last two quarters.
ICUI: 125.47 (+0.26), ZLTQ: 38.09 (-0.12), AXDX: 22.37 (+0.37), NVRO: 96.56 (+0.54)

FDA Okays Trial for Medtronic's MRI-Guided Epilepsy Device
Zacks Equity Research - Zacks Investment Research - Fri Jun 24, 6:31AM CDT
With surgical procedures gaining ground in the treatment of drug-resistant epilepsy, the FDA go-ahead will expand Medtronic's (MDT) footprint in the billion-dollar neurosurgical market.
ICUI: 125.47 (+0.26), MDT: 87.63 (+0.65), BAX: 46.10 (-0.08), LMAT: 18.11 (+0.35)

Hologic: FDA Okays Procleix Zika Virus Test under IND Study
Zacks Equity Research - Zacks Investment Research - Wed Jun 22, 7:51AM CDT
Hologic's (HOLX) Procleix Zika Virus Test was approved under FDA???s Investigational New Drug (IND) study protocol to detect the presence of Zika virus in donated blood.
ICUI: 125.47 (+0.26), BAX: 46.09 (-0.09), LMAT: 18.11 (+0.35), HOLX: 38.56 (+0.10)

Hill-Rom Introduces VisiVest, First Connected Airways System
Zacks Equity Research - Zacks Investment Research - Mon Jun 20, 8:19AM CDT
Hill-Rom Holdings, Inc. (HRC) recently launched VisiVest System, the world's first wirelessly connected airway clearance system.
ICUI: 125.47 (+0.26), LMAT: 18.11 (+0.35), NUVA: 66.37 (+0.31), HRC: 59.84 (+0.59)

Hologic's Zika Virus Test Gets FDA Nod for Emergency Use
Zacks Equity Research - Zacks Investment Research - Mon Jun 20, 7:58AM CDT
Hologic (HOLX) will run the Aptima Zika virus test on its market leading Panther platform, which substantially reduces hands-on time for laboratories and the potential for manual errors.
ICUI: 125.47 (+0.26), BAX: 46.09 (-0.09), LMAT: 18.11 (+0.35), HOLX: 38.56 (+0.10)

Bruker Well Poised on Product Innovation amid Currency Woes
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 6:23AM CDT
On Jun 14, we issued an updated research report on Billerica, MA-based Bruker Corporation (BRKR).
ICUI: 125.47 (+0.26), LMAT: 18.11 (+0.35), BRKR: 22.34 (-0.10), NUVA: 66.37 (+0.31)

Boston Scientific: Restructuring Plan, Global Growth Impress
Zacks Equity Research - Zacks Investment Research - Tue Jun 14, 6:14AM CDT
On Jun 13, 2016, we issued an updated research report on Boston Scientific Corporation (BSX).
BSX: 24.18 (-0.15), ICUI: 125.47 (+0.26), BAX: 46.09 (-0.09), LMAT: 18.11 (+0.35)

PetMed Remains Strong on New Order & Reorder Sales Gain
Zacks Equity Research - Zacks Investment Research - Mon Jun 13, 10:15AM CDT
On Jun 13, 2016, we issued an updated research report on PetMed Express (PETS).
ICUI: 125.47 (+0.26), PETS: 20.39 (+0.20), LMAT: 18.11 (+0.35), NUVA: 66.37 (+0.31)

Zimmer Biomet's Spine Business to Get a Boost with LDR Buy
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 6:00AM CDT
Zimmer Biomet Holdings, Inc. (ZBH) has entered into a definitive agreement to acquire LDR Holding Corp. (LDRH) for a total deal value of $1 billion.
BSX: 24.18 (-0.15), ICUI: 125.47 (+0.26), ZBH: 129.28 (+0.93), LDRH: 36.98 (-0.02)

NuVasive to Strengthen Spine Service Line with Biotronic Buy
Zacks Equity Research - Zacks Investment Research - Tue Jun 07, 7:17AM CDT
NuVasive, Inc. (NUVA) recently entered into a definitive agreement to acquire privately held Biotronic NeuroNetwork.
BSX: 24.18 (-0.15), ICUI: 125.47 (+0.26), BAX: 46.09 (-0.09), NUVA: 66.37 (+0.31)

Abaxis (ABAX): Solid Veterinary Show Despite Global Hiccups
Zacks Equity Research - Zacks Investment Research - Mon Jun 06, 5:01AM CDT
On Jun 3, 2016, we issued an updated research report on Abaxis, Inc. (ABAX). The stock currently carries a Zacks Rank #4 (Sell).
ICUI: 125.47 (+0.26), ABAX: 50.15 (-0.25), LMAT: 18.11 (+0.35), NUVA: 66.37 (+0.31)

Medtronic (MDT) Posts Solid Q4; Covidien Synergy Continues
Zacks Equity Research - Zacks Investment Research - Fri Jun 03, 6:31AM CDT
On Jun 3, 2016, we issued an updated research report on Medtronic plc (MDT).
BSX: 24.18 (-0.15), ICUI: 125.47 (+0.26), MDT: 87.63 (+0.65), LMAT: 18.11 (+0.35)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Unpacking RAGEism: Power Dynamics in U.S. Policies

Seeing Patterns in Crisis: Jackson and Flint When Jackson, Mississippi's latest water crisis hit the news, it wasn't the first time folks were left high and dry. No, this fiasco's got deep roots, and it resonates with another infamous case: Flint, Michigan. In Maya Rockeymoore Cummings' book, RAGEism, these are badge-worthy examples of 'Resource Hoarding' where government...

Maurices Strengthens Position with Key Refinancing Deal

Maurices' Bold Financial Maneuver When a retailer like Maurices, with its near-century-long history, decides to play in the financial arena, it sure makes my ears perk up. This Duluth-based women's fashion retailer isn't just dipping its toes in—it's executing a full-blown refinancing blitzkrieg and coming out stronger. Announcing the completion of its refinancing plan...

Rare Collectibles Highlight Morphy's Auction on Oct 4

Anticipation Builds for Morphy's Auction Event Morphy's upcoming event on October 4th is all about tapping into the era of revved engines, gleaming gasoline signs, and some history that could put Hollywood tales to shame. The auction isn't just a stroll down memory lane; it features over 650 lots, each a time capsule of America's automotive past. From Al Capone's ritzy...

AI Trust in Finance: Survey Reveals Market Impact

Trust in AI for Financial Guidance: Where Are We Headed? The market winds shift with every sunrise, and today’s buzzword? Artificial Intelligence. You’d almost think AI’s trying to steal my job along with every other trader’s mojo. But here's the twist—A survey from Possible Finance shows about 15% of folks would actually lean on AI for their financial advice....

Cap Juluca: Caribbean Luxury Redefined on Maundays Bay

The Tranquil Call of Maundays Bay Find me dipping my toes in the sands of Maundays Bay come October 10, 2026, and you'll understand why this slice of Anguilla stakes its claim to being the best beach on the globe. Cap Juluca, that crown jewel of Caribbean luxury, swings open its doors once more, promising indulgence framed by turquoise waters and the soft whisper of white...

Navigating Land Access: The Hidden Roadblock in Mining

Mining's Often Overlooked Obstacle: Land Access In the world of mining, the shallow thrills of striking gold are often overshadowed by the frustrating slog of securing land access. You can have your permits lined up, your finances sorted, and drills humming along, but if you haven’t sweet-talked the folks farming above your visible vein of riches, you could be staring...

Albertsons Welcomes Once Upon a Coconut Nationwide

Coconut Water Takes Over Grocery Aisles You know, for all the cautious optimism I wield, this here is a move that shows real muscle in the world of coconut water—I mean, slamming into Albertsons' grocery empire is no small potatoes! Once Upon a Coconut has landed its premium hydration cans across all the banners under this giant retailer. From that good ol' familiar...

Cannabis Industry Pushes for Robust Financial Services

Industry Gears Up for Financial Action Clearly, cannabis businesses are shouting louder than a vendor at a ballgame, demanding more than just the basic chips-and-soda banking service. They’re on the hunt for serious credit facilities, payments, and the traditional financial tools that most sectors take for granted. I mean, check this out: Shield Compliance just dropped...

WNET's 25th Anniversary 9/11 Tribute: Stories and Lessons

Reflecting on a Dark Day with WNET's Programming Nothing quite hits you like the anniversary of a colossal tragedy. The memories of September 11, 2001, remain etched in the urban landscape of New York City, and this year marks 25 years since that heart-wrenching day. The WNET Group steps up to the plate with a comprehensive slate of programming aimed at honoring the...

Tampa General’s Innovation Excellence Earns No. 20 Spot

A Bold Leap into Innovation at Tampa General There's a heck of a lot going on down in Tampa that's worth more than just a golf clap. Tampa General Hospital (TGH) just snagged the 20th spot on Fast Company's Best Workplaces for Innovators list, and let me tell you, that’s no small feat amidst the heavy hitters in verticals like biotech and consumer goods. It takes guts...